Optimized interval treatment of eczema with fluprednidene. a multicenter double-blind study

Mahrle, G.; Wemmer, U.; Matthies, C.

Zeitschrift für Hautkrankheiten 64(9): 766-768; 773-774

1989


ISSN/ISBN: 0301-0481
PMID: 2683439
Document Number: 4400
In a multicenter double-blind study, 44 patients suffering from eczema were bilaterally treated with 0.1% fluprednidene-21-acetate over 21 days. Continuous application twice a day was compared with intermittent therapy, i.e. 1 day intermission (15 patients), 2 days intermission (16 patients) and 3 days intermission (13 patients) using the cream base. Final evaluation was based on 11 criteria. All regimens, continuous and intermittent, proved effective (at least 90% reduction of the lesions). Treatment with 3 days intermission showed the same favorable results as continuous application, although the amount of glucocorticoids applied was 75% less. Measurements of the skin fold thickness (SFT) in healthy controls did not indicate any atrophy after treatment with fluprednidene under the same conditions as the eczema patients or under occlusion for up to 21 days. Clobetasol-17-propionate, in contrast, significantly reduced the SFT already after application of only 1 week.

Document emailed within 1 workday
Secure & encrypted payments

Optimized interval treatment of eczema with fluprednidene. a multicenter double-blind study